US 11299546
FLT3-specific chimeric antigen receptors and methods using same
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 11299546 (FLT3-specific chimeric antigen receptors and methods using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/48